Saturday 17 October 2026
Export GEHC’s income statement to Excel — free account
GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
69.57
0.78
−1.11%
Follow GEHC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| 19.15% | 19.20% | 22.11% | 24.16% | ||
| 5.45% | 5.40% | 5.95% | 6.34% | ||
ROIC |
8.37% | 8.30% | 9.84% | 9.60% | |
Return on Tangible Assets |
37.15% | 38.24% | 32.12% | 45.90% | |
Average Days of Receivables |
66.61 | 65.87 | 69.99 | 67.31 | |
Free Cash Flow per Share |
3.49 | 3.33 | 3.30 | 3.07 | |
Free Cash Flow |
1,579.00 | 1,519.00 | 1,505.00 | 1,400.00 | |
Capital Expenditures |
(522.00) | (508.00) | (482.00) | (450.00) | |
| Other line items | |||||
Cash ROIC |
6.41% | 6.20% | 5.66% | 5.41% | |
Accounts Receivable Turnover |
5.71 | 5.70 | 5.48 | 5.66 | |
Accounts Payable Turnover |
4.14 | 3.89 | 3.94 | 4.06 | |
Inventory Turnover |
5.40 | 5.66 | 5.93 | 5.41 | |
Average Days of Payables |
91.71 | 97.49 | 95.84 | 90.97 | |
Days of Inventory on Hand |
70.48 | 67.27 | 65.88 | 70.17 | |
Tax Rate |
(0.23) | (0.23) | (0.22) | (0.18) | |
Research and Development Expense of Revenue |
6.03% | 6.01% | 6.11% | 6.33% | |
Selling, General and Administrative Expense of Revenue |
20.65% | 20.51% | 20.48% | 20.96% | |
Share Based Compensation of Revenue |
0.72% | 0.68% | 0.63% | 0.63% | |
Operating CF/Net income |
1.06 | 1.06 | 0.95 | 0.83 | |
Depreciation/Fixed assets |
0.19 | 0.19 | 0.19 | 0.19 | |
Capex/Depreciation |
(0.86) | (0.85) | (0.83) | (0.79) | |
Revenue per Share |
46.95 | 46.01 | 45.23 | 44.40 | |
Operating CF per Share |
4.64 | 4.45 | 4.36 | 4.06 | |
Capex per Share |
(1.15) | (1.11) | (1.06) | (0.99) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates